AXT, Inc.

NasdaqGS:AXTI 주식 리포트

시가총액: US$7.8b

AXT 과거 순이익 실적

과거 기준 점검 0/6

AXT 의 수입은 연평균 -59.7%의 비율로 감소해 온 반면, Semiconductor 산업은 연평균 1.8%의 비율로 증가했습니다. 매출은 연평균 9.9%의 비율로 감소해 왔습니다.

핵심 정보

-59.66%

순이익 성장률

-59.47%

주당순이익(EPS) 성장률

Semiconductor 산업 성장률27.66%
매출 성장률-9.91%
자기자본이익률-4.35%
순이익률-14.87%
최근 순이익 업데이트31 Mar 2026

최근 과거 실적 업데이트

Recent updates

Seeking Alpha • May 04

AXT Inc. Hits New All-Time Highs On Strong Earnings And Forward Outlook

Summary AXT, Inc. delivered strong Q1-2026 results driven by high demand for Indium Phosphide. AXT plans to expand its Indium Phosphide capacity over the next two years. The AXT stock price has gained 7,000% over the last year and is now extremely overvalued. I continue my rating of a hold for AXT stock. Read the full article on Seeking Alpha
내러티브 업데이트 • Apr 29

AXTI: Future InP Substrate Demand Will Outweigh Near Term Export Constraints

Narrative Update on AXT The analyst price target for AXT has moved from $45 to $90, with analysts pointing to higher assumed profit margins, an increased future P/E multiple, and stronger long term InP substrate demand expectations supported by recent capacity and capex plans at major optical and cloud players. Analyst Commentary Recent Street research on AXT highlights a mix of optimism on long term InP substrate demand and some short term caution around export related constraints.
내러티브 업데이트 • Apr 14

AXTI: Export Permit Limits Will Continue To Restrain InP AI Upside

Analysts have raised AXT's fair value estimate from $28.25 to $30.75, reflecting updated views on higher potential P/E multiples, supported by expected InP growth and recent price target increases from several research firms. Analyst Commentary Recent research gives you a mixed but useful read on how the Street is thinking about AXT, with some focusing on long term InP growth potential and others highlighting nearer term execution risks and regulatory overhangs.
내러티브 업데이트 • Mar 31

AXTI: Export Permit Constraints Will Limit Upside Despite InP Demand Story

AXT's analyst fair value estimate has been raised from $26.00 to $45.00 as analysts factor in expectations for higher revenue, stronger profit margins, and a richer forward P/E multiple supported by rising Street price targets related to InP demand and export permit clarity. Analyst Commentary Recent research on AXT points to a split view, with some caution around near term export permit issues, but also a series of more optimistic calls that connect the story to longer term compound semiconductor demand and valuation support tied to InP exposure.
내러티브 업데이트 • Mar 17

AXTI: Export Permit Constraints Will Limit Benefit Of InP Demand Optimism

The analyst price target for AXT has increased from $8.50 to $21, with analysts citing stronger InP growth expectations, higher projected profit margins, and a higher assumed future P/E multiple as key supports for the updated valuation framework. Analyst Commentary Recent Street research on AXT reflects a wide spread in price targets, with some analysts using relatively high P/E multiples based on long term InP growth expectations and others taking a more cautious stance as they weigh near term execution risks and policy related constraints.
내러티브 업데이트 • Mar 03

AXTI: InP Export Permit Constraints Will Undermine AI Demand Upside Potential

Narrative Update on AXT The analyst price targets for AXT have moved sharply higher, with recent updates ranging from $21 to $35. Analysts are factoring in higher fair value estimates and stronger InP growth expectations, despite ongoing export permit uncertainty.
내러티브 업데이트 • Feb 17

AXTI: Neutral Stance Will Reflect Export Permit Risks And Equity Raise

Narrative Update on AXT Price Target Analysts have raised their AXT price target from $9 to $18, citing updated assumptions for higher revenue growth and profit margins, as well as a lower discount rate. At the same time, they have shifted to a Neutral stance following export permit related headwinds in InP substrate shipments.
내러티브 업데이트 • Feb 03

AXTI: Export Permit Constraints And Equity Offering Will Pressure Future Returns

Analysts have raised their price target on AXT to US$18 from US$9, citing valuation after the company adjusted its Q4 revenue outlook due to fewer export permits for InP substrates from the Chinese government. Analyst Commentary Bearish analysts are framing the new US$18 price target as less about improving fundamentals and more about the stock having already run ahead of what they see as reasonable expectations.
내러티브 업데이트 • Jan 20

AXTI: Export Permit Uncertainty Will Constrain Near Term Revenue Outlook

Analysts have lifted their price targets for AXT, with moves such as from US$4.10 to US$7 and from US$9 to US$18, citing changing views on export permit progress, revenue assumptions, and valuation. Analyst Commentary Recent Street research on AXT reflects a mixed backdrop, with some bearish analysts turning more cautious even as price targets move higher.
내러티브 업데이트 • Jan 05

AXTI: Export Permits Will Drive Fragile Near Term Revenue Expectations

Analysts lifted their price target on AXT to $7.00 from $4.10, pointing to updated Q3 revenue assumptions after the company received export permits from China's Ministry of Commerce to resume shipping indium phosphide substrates to additional customers. Analyst Commentary Analysts point to the new export permits as a key reason for revisiting their models, with Q3 revenue assumptions adjusted to reflect the potential contribution from indium phosphide substrate shipments to additional customers.
분석 기사 • Dec 19

AXT, Inc.'s (NASDAQ:AXTI) 39% Share Price Surge Not Quite Adding Up

AXT, Inc. ( NASDAQ:AXTI ) shares have continued their recent momentum with a 39% gain in the last month alone. The last...
내러티브 업데이트 • Dec 14

AXTI: New Export Permits Will Intensify Regulatory And Execution Downside Risks

Analysts have raised their price target on AXT by approximately $2.90 per share to around $7.00, citing improved revenue expectations after the company received new export permits that enable it to resume shipping indium phosphide substrates to additional customers. Analyst Commentary Analysts are updating their models ahead of upcoming quarterly results, reflecting the impact of newly granted export permits on AXT's near term revenue and margin profile.
내러티브 업데이트 • Nov 30

AXTI: Export Permit Reliance Will Heighten Downside Risks Amid Ongoing Uncertainty

Analysts have increased their price target for AXT to $7 from $4.10, citing higher anticipated revenues because the company recently obtained export permits that allow it to ship indium phosphide substrates to additional customers. Analyst Commentary Recent updates from the analyst community reflect a reassessment of AXT's growth prospects and financial outlook following the news about new export permits for indium phosphide substrates.
내러티브 업데이트 • Nov 16

AXTI: Renewed Export Permits Will Influence Recovery Amid Regulatory Risks

Analysts have raised AXT's fair value estimate significantly from $5.70 to $9.50 per share, citing improved revenue assumptions following renewed export permits and a higher price target in recent research updates. Analyst Commentary Analyst reactions to AXT's recent developments have brought both optimism and caution regarding the company's future prospects and valuation.
내러티브 업데이트 • Nov 02

AXTI: Export Permit Uncertainty Will Challenge Margin Strength Moving Forward

The analyst price target for AXT has increased significantly from $3.82 to $5.70 per share, as analysts cite improved revenue growth expectations and recent export permit approvals as key drivers behind their revised outlook. Analyst Commentary Analyst sentiment regarding AXT has evolved in response to recent company developments, with notable optimism about future growth prospects.
분석 기사 • Oct 14

AXT, Inc. (NASDAQ:AXTI) Shares Fly 26% But Investors Aren't Buying For Growth

AXT, Inc. ( NASDAQ:AXTI ) shares have continued their recent momentum with a 26% gain in the last month alone. Looking...
분석 기사 • Oct 08

Here's Why AXT (NASDAQ:AXTI) Can Afford Some Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Jul 20

AXT, Inc. (NASDAQ:AXTI) Stock Catapults 33% Though Its Price And Business Still Lag The Industry

Despite an already strong run, AXT, Inc. ( NASDAQ:AXTI ) shares have been powering on, with a gain of 33% in the last...
User avatar
새로운 내러티브 • May 02

Chinese Data Center Demand And Laser Tech Will Open New Markets

Strategic positioning in the Chinese data center market and local sourcing aims to reduce foreign dependency and boost revenue growth.
Seeking Alpha • Feb 24

AXT, Inc. Reported Improved Q4 Financial Performance But Q1 Outlook Disappoints

Summary AXT, Inc. reported increased revenues QoQ and YoY due to higher demand for its indium phosphide wafers. The company expects lower Q1 2025 revenues due to new regulations in China over exports of indium phosphide. The company’s stock price hit its 52-week low last Friday due to the weak Q1 outlook. The company still foresees strong performance during 2025 and 2026 regardless of the setback. I rate AXTI stock as a Hold for now and recommend that investors watch the company for developments. Read the full article on Seeking Alpha
Seeking Alpha • Oct 26

AXT, Inc.: Not Getting The Recognition It Deserves

Summary AXT, Inc. came close to multi-year lows last September after a selloff following guidance, but history suggests that might have been a good entry point. Guidance suggests AXTI will grow slower, at least in the short term, but there is nonetheless much more to remain upbeat about. There have been setbacks, including in terms of AI, but AXTI is still growing and on pace to get back to earning a profit as soon as next year. It may take some time and patience, but long AXTI still looks like it has what it takes to become a winning play. Read the full article on Seeking Alpha
Seeking Alpha • Aug 05

AXT, Inc.: Downgrading On Limited Visibility And Early Cracks In The AI Story

Summary Semiconductor substrate provider AXT, Inc. reported better-than-expected Q2/2024 results, with both revenues and profitability coming in ahead of consensus estimates. Strong sequential growth in gallium arsenide and germanium substrate sales were partially offset by a decrease in indium phosphide revenues. However, Q3 guidance came in below consensus expectations due to an anticipated sequential decline in substrate revenues. While the company looks cheap following Friday's selloff, limited visibility and a rather lumpy AI revenue ramp are likely to keep the stock in the penalty box for at least the next couple of months. Given these issues, I am downgrading the company's stock from "Buy" to "Hold". Read the full article on Seeking Alpha
Seeking Alpha • Jul 21

AXT Inc.: Playing An Expected Rebound

Summary The stock has sold off in the last three days due to AXTI’s ties to China, but this could be an opportunity to take advantage of. AXTI is valued at much less than book value, which could become untenable if AXTI gets out of the red in 2025. AXTI is scheduled to release the Q2 report on August 1 and the conditions are there for a repeat of what happened twice before in 2024. The China factor will not go away anytime soon, but long AXTI has enough in its favor to make it worth backing. Read the full article on Seeking Alpha
Seeking Alpha • May 07

AXT: Strong Outlook As Business Recovery Is Picking Up Steam - Buy

Summary Semiconductor substrate provider AXT, Inc. reported Q1/2024 results in line with its April 8 preannouncement and provided Q2 guidance well ahead of expectations. The company's substrate business continues to recover across all major product lines, with some AI-related demand contributing to a 50% sequential increase in indium phosphide sales. Management expects the company to reach breakeven levels by the end of this year or early next year. The company is considering monetizing some of its holdings in a number of Chinese raw materials providers. Risk/reward is looking increasingly favorable for speculative investors, with the business recovering across the board and a number of potential near- and medium-term catalysts. Reiterating "Buy" rating with a near-term price target of $5.30. Read the full article on Seeking Alpha
Seeking Alpha • Apr 05

AXT: Selloff Provides Buying Opportunity

Summary A plethora of allegations raised in a new shortseller report caused AXT, Inc.'s shares to crater by 35%. The core short thesis is centering around the risks resulting from a potential failure to list Chinese subsidiary Tongmei on the Shanghai Star Market. However, these risks have been adequately disclosed by the company in recent years and should be well-known among market participants following AXT more closely. In addition, the company's business is showing early signs of life after a couple of abysmal quarters with analysts projecting a full-blown recovery for next year. In my opinion, Thursday's selloff provides speculative investors an opportunity to initiate positions in a recovering business driven by exposure to the red hot data center and AI market. Should AXT execute at least in line with current analyst expectations, the stock might approach $6 next year. Read the full article on Seeking Alpha

매출 및 비용 세부 내역

AXT가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.

순이익 및 매출 추이

NasdaqGS:AXTI 매출, 비용 및 순이익 (USD Millions)
날짜매출순이익일반관리비연구개발비
31 Mar 2696-14259
31 Dec 2588-21249
30 Sep 2590-232411
30 Jun 2586-242413
31 Mar 2596-192414
31 Dec 2499-122415
30 Sep 2495-102313
30 Jun 2488-132313
31 Mar 2479-172312
31 Dec 2376-182312
30 Sep 2382-132313
30 Jun 23100-22414
31 Mar 2312192514
31 Dec 22141162614
30 Sep 22152172613
30 Jun 22151152612
31 Mar 22146142511
31 Dec 21137142410
30 Sep 21127132310
30 Jun 2111811219
31 Mar 211067208
31 Dec 20953197
30 Sep 2087-1197
30 Jun 2081-3196
31 Mar 2084-2196
31 Dec 1983-3196
30 Sep 1987-2196
30 Jun 19963196
31 Mar 19985206
31 Dec 181029196
30 Sep 1810614196
30 Jun 1810614186
31 Mar 1810212175
31 Dec 179910175
30 Sep 17939165
30 Jun 17867155
31 Mar 17836146
31 Dec 16815146
30 Sep 16792136
30 Jun 16760146
31 Mar 1676-1146
31 Dec 1578-2166
30 Sep 1579-1176
30 Jun 1584-1175

양질의 수익: AXTI 은(는) 현재 수익성이 없습니다.

이익 마진 증가: AXTI는 현재 수익성이 없습니다.

잉여현금흐름 대비 순이익 분석

과거 순이익 성장 분석

수익추이: AXTI은 수익성이 없으며 지난 5년 동안 손실이 연평균 59.7% 증가했습니다.

성장 가속화: 현재 수익성이 없어 지난 1년간 AXTI의 수익 성장률을 5년 평균과 비교할 수 없습니다.

수익 대 산업: AXTI은 수익성이 없어 지난 해 수익 성장률을 Semiconductor 업계(12.3%)와 비교하기 어렵습니다.

자기자본이익률

높은 ROE: AXTI는 현재 수익성이 없으므로 자본 수익률이 음수(-4.35%)입니다.

총자산이익률

투하자본수익률

우수한 과거 실적 기업을 찾아보세요

7D

1Y

7D

1Y

7D

1Y

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/05/14 02:52
종가2026/05/14 00:00
수익2026/03/31
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

AXT, Inc.는 7명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Ku KangB. Riley Securities, Inc.
Hamed KhorsandBWS Financial Inc.
Richard ShannonCraig-Hallum Capital Group LLC